Acetic Acid → HCID 493368, compound
Reaction equation
C(=O)([O-])[O-].[Na+].[Na+].[Br:7][C:8]1[N:12]([C@H:13]2[O:25][C@@H:24]([CH2:26][O:27]C(=O)C)[C@H:19]([O:20]C(=O)C)[C@@H:14]2[O:15]C(=O)C)[C:11]2[CH:31]=[C:32]([Cl:36])[C:33]([Cl:35])=[CH:34][C:10]=2[N:9]=1.O.C(O)(=O)C>C(Cl)Cl.C(O)C.CO>[Br:7][C:8]1[N:12]([C@H:13]2[O:25][C@@H:24]([CH2:26][OH:27])[C@H:19]([OH:20])[C@@H:14]2[OH:15])[C:11]2[CH:31]=[C:32]([Cl:36])[C:33]([Cl:35])=[CH:34][C:10]=2[N:9]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
Sodium carbonate (0.28 g, 2.65 mmol) and 2-bromo-5,6-dichloro-1-(2,3,5-tri-O-acetyl-β-L-ribofuranosyl)-1H-benzimidazole (1.39 g, 2.65 mmol) were combined with water (4 mL), methanol (20 mL) and ethanol (20 mL) and stirred at rt for 1.5 h. Acetic acid (0.3 mL, 5.3 mmol) was added and the suspension was concentrated to a solid. Purification of the residue on a silica gel column (2.5×20 cm, 230-400 mesh) with 1:9 ethanol:CH2Cl2 gave the title compound as a white amorphous solid (0.79 g, 2.0 mmol, 75%); m.p. 169° C.; [α]20D=(+)105 (c=0.5 DMF); UVλmax (E) pH=7.0: 298 nm (6,700), 289 (6,500), 255 (6,900); 0.1 nNaOH: 298 nm (6,700), 295 (5,400), 256 (6,700); MS (CI): m/z 399 (M+); 1H NMR (DMSO-d6) d 8.57 (s, 1H, Ar—H), 7.96 (s, 1H, Ar—H), 5.89 (d, J=7.9 Hz, H-1′), 5.48 (d, 1H, OH, J=6.3 Hz), 5.42 (t, 1H, OH, J=4.5 Hz), 5.29 (d, 1H, OH, J=4.2 Hz), 4.43 (apparent dd, 1H, H-2′, J=13.3 Hz, J=6.1 Hz), 4.14 (apparent t, 1H, H-3′, J=4.3 Hz), 4.01 (apparent d, 1H, H-4′, J=1.7 Hz), 3.77-3.63 (m, 2H, H-5′).
Workup
- concentrationthe suspension was concentrated to a solid
- customPurification of the residue on a silica gel column (2.5×20 cm, 230-400 mesh) with 1:9 ethanol
Sources & evidence
- ORD record
- ord-ddad2fd983a9492c8ea69671c925b2e7
- Source dataset
- uspto-grants-2009_04
- Patent number
- US07514568B2
Reaction notes
Loading…